BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 27548324)

  • 21. Regulation of T cell lineage commitment by SMAR1 during inflammatory & autoimmune diseases.
    Mirlekar B; Majumdar S; Khetmalas M; Chattopadhyay S
    Indian J Med Res; 2015 Oct; 142(4):405-13. PubMed ID: 26609032
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Regulatory T cells suppress development of colitis, blocking differentiation of T-helper 17 into alternative T-helper 1 cells.
    Sujino T; Kanai T; Ono Y; Mikami Y; Hayashi A; Doi T; Matsuoka K; Hisamatsu T; Takaishi H; Ogata H; Yoshimura A; Littman DR; Hibi T
    Gastroenterology; 2011 Sep; 141(3):1014-23. PubMed ID: 21699791
    [TBL] [Abstract][Full Text] [Related]  

  • 23. B Cell-Activating Transcription Factor Plays a Critical Role in the Pathogenesis of Anti-Major Histocompatibility Complex-Induced Obliterative Airway Disease.
    Xu Z; Ramachandran S; Gunasekaran M; Nayak D; Benshoff N; Hachem R; Gelman A; Mohanakumar T
    Am J Transplant; 2016 Apr; 16(4):1173-82. PubMed ID: 26844425
    [TBL] [Abstract][Full Text] [Related]  

  • 24. IL-23R+ innate lymphoid cells induce colitis via interleukin-22-dependent mechanism.
    Eken A; Singh AK; Treuting PM; Oukka M
    Mucosal Immunol; 2014 Jan; 7(1):143-54. PubMed ID: 23715173
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Th17 Cells as Potential Probiotic Therapeutic Targets in Inflammatory Bowel Diseases.
    Owaga E; Hsieh RH; Mugendi B; Masuku S; Shih CK; Chang JS
    Int J Mol Sci; 2015 Sep; 16(9):20841-58. PubMed ID: 26340622
    [TBL] [Abstract][Full Text] [Related]  

  • 26. miR-340 affects sauchinone inhibition of Th17 cell differentiation and promotes intestinal inflammation in inflammatory bowel disease.
    Chen Q; He Q; Xiu W; Chen Y; Guo Z
    Biochem Biophys Res Commun; 2020 Jun; 526(4):1157-1163. PubMed ID: 32321642
    [TBL] [Abstract][Full Text] [Related]  

  • 27. IL-6-gp130-STAT3 in T cells directs the development of IL-17+ Th with a minimum effect on that of Treg in the steady state.
    Nishihara M; Ogura H; Ueda N; Tsuruoka M; Kitabayashi C; Tsuji F; Aono H; Ishihara K; Huseby E; Betz UA; Murakami M; Hirano T
    Int Immunol; 2007 Jun; 19(6):695-702. PubMed ID: 17493959
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Protective role of R381Q (rs11209026) polymorphism in IL-23R gene in immune-mediated diseases: A comprehensive review.
    Abdollahi E; Tavasolian F; Momtazi-Borojeni AA; Samadi M; Rafatpanah H
    J Immunotoxicol; 2016 May; 13(3):286-300. PubMed ID: 27043356
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Transcriptional Regulators of T Helper 17 Cell Differentiation in Health and Autoimmune Diseases.
    Capone A; Volpe E
    Front Immunol; 2020; 11():348. PubMed ID: 32226427
    [TBL] [Abstract][Full Text] [Related]  

  • 30. RORgamma-expressing Th17 cells induce murine chronic intestinal inflammation via redundant effects of IL-17A and IL-17F.
    Leppkes M; Becker C; Ivanov II; Hirth S; Wirtz S; Neufert C; Pouly S; Murphy AJ; Valenzuela DM; Yancopoulos GD; Becher B; Littman DR; Neurath MF
    Gastroenterology; 2009 Jan; 136(1):257-67. PubMed ID: 18992745
    [TBL] [Abstract][Full Text] [Related]  

  • 31. T-helper 17 and interleukin-17-producing lymphoid tissue inducer-like cells make different contributions to colitis in mice.
    Ono Y; Kanai T; Sujino T; Nemoto Y; Kanai Y; Mikami Y; Hayashi A; Matsumoto A; Takaishi H; Ogata H; Matsuoka K; Hisamatsu T; Watanabe M; Hibi T
    Gastroenterology; 2012 Nov; 143(5):1288-1297. PubMed ID: 22850180
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacological Evaluation of TAK-828F, a Novel Orally Available RORγt Inverse Agonist, on Murine Colitis Model.
    Igaki K; Nakamura Y; Komoike Y; Uga K; Shibata A; Ishimura Y; Yamasaki M; Tsukimi Y; Tsuchimori N
    Inflammation; 2019 Feb; 42(1):91-102. PubMed ID: 30121880
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intestinal neuroendocrine cells and goblet cells are mediators of IL-17A-amplified epithelial IL-17C production in human inflammatory bowel disease.
    Friedrich M; Diegelmann J; Schauber J; Auernhammer CJ; Brand S
    Mucosal Immunol; 2015 Jul; 8(4):943-58. PubMed ID: 25492478
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Blockade of IL-6 signal exacerbates acute inflammatory bowel disease via inhibiting IL-17 producing in activated CD4+ Th17 population.
    Zhang SJ; Wang L; Ming L; Guo XB; Wang HM; Li XW; Li L
    Eur Rev Med Pharmacol Sci; 2013 Dec; 17(24):3291-5. PubMed ID: 24379058
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment with IL-27 attenuates experimental colitis through the suppression of the development of IL-17-producing T helper cells.
    Sasaoka T; Ito M; Yamashita J; Nakajima K; Tanaka I; Narita M; Hara Y; Hada K; Takahashi M; Ohno Y; Matsuo T; Kaneshiro Y; Tanaka H; Kaneko K
    Am J Physiol Gastrointest Liver Physiol; 2011 Apr; 300(4):G568-76. PubMed ID: 21193526
    [TBL] [Abstract][Full Text] [Related]  

  • 36. JunB is essential for IL-23-dependent pathogenicity of Th17 cells.
    Hasan Z; Koizumi SI; Sasaki D; Yamada H; Arakaki N; Fujihara Y; Okitsu S; Shirahata H; Ishikawa H
    Nat Commun; 2017 May; 8():15628. PubMed ID: 28555647
    [TBL] [Abstract][Full Text] [Related]  

  • 37. RORγt(+) hematopoietic cells are necessary for tumor cell proliferation during colitis-associated tumorigenesis in mice.
    Martin M; Kesselring RK; Saidou B; Brunner SM; Schiechl G; Mouris VF; Wege AK; Rümmele P; Schlitt HJ; Geissler EK; Fichtner-Feigl S
    Eur J Immunol; 2015 Jun; 45(6):1667-79. PubMed ID: 25820779
    [TBL] [Abstract][Full Text] [Related]  

  • 38. BATF2 prevents T-cell-mediated intestinal inflammation through regulation of the IL-23/IL-17 pathway.
    Kayama H; Tani H; Kitada S; Opasawatchai A; Okumura R; Motooka D; Nakamura S; Takeda K
    Int Immunol; 2019 May; 31(6):371-383. PubMed ID: 30753547
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of miR-22 in intestinal mucosa tissues and peripheral blood CD4+ T cells of inflammatory bowel disease.
    Pei XF; Cao LL; Huang F; Qiao X; Yu J; Ye H; Xi CL; Zhou QC; Zhang GF; Gong ZL
    Pathol Res Pract; 2018 Aug; 214(8):1095-1104. PubMed ID: 29880327
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Th17-related cytokines in inflammatory bowel diseases: friends or foes?
    Monteleone I; Sarra M; Pallone F; Monteleone G
    Curr Mol Med; 2012 Jun; 12(5):592-7. PubMed ID: 22515978
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.